期刊
NATURE
卷 446, 期 7139, 页码 1000-1007出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature05813
关键词
-
资金
- NIGMS NIH HHS [R01 GM058833-10] Funding Source: Medline
Therapeutic vaccines derived from carbohydrate antigen - adjuvant combinations are a promising approach for cancer immunotherapy. One of the critical limitations in this area is access to sufficient quantities of tumour-associated carbohydrate antigens and glycoconjugate adjuvants. At present, availability of the complex oligosaccharide constructs that are needed for the systematic design and evaluation of novel vaccine formulations relies on de novo chemical synthesis. The use of both state-of-the-art and emerging glycosylation technologies has led to significant advances in this field, allowing the clinical exploration of carbohydrate-based antigens in the treatment of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据